Increased GMP Enforcement By China Demands Regulatory Fluency
This article was originally published in The Tan Sheet
China's FDA substantially beefs up inspections of foreign firms' manufacturing sites, showing assertiveness toward the country's GMP standards after a massive domestic campaign to root out violators. Staying compliant in the second largest pharma market requires staying on top of local regulatory updates.
Register for our free email digests: